Childhood obesity may be a significant predictor of adverse outcomes and lower survival rates in cancer patients, reveals a study published in the journal CANCER.
Around 10.5% of the 11,291 Canadian children below the age of 18 diagnosed with cancer between 2001 and 2020 were obese, which was determined using the Body Mass Index (BMI) at or above the 95th percentile.
The study shows that obese patients had five-year event-free survival rates of 77.5%, with 83.0% overall survival rates, compared with 79.6% and 85.9%, respectively, for non-obese patients.
The findings indicate a 16% increase in relapse risk and a towering 29% increase in mortality risk linked to obesity at diagnosis.
The correlation between obesity and survival rates proves significant with respect to certain types of childhood cancers, such as acute lymphoblastic leukemia and brain tumors.
The study is a wake-up call for the healthcare industry to prioritize obesity management in pediatric oncology, which will lead to better outcomes and quality of life for affected children.
The study also highlights the role of obesity in childhood cancer prognosis and calls for comprehensive cancer care that will focus on fostering a living environment conducive to healthy habits with physical activities, mental health support and healthy nutrition as vital components of treatment.
Health professionals and policymakers need to make efforts to prevent and control the childhood obesity epidemic as part of public health initiatives because it poses health risks to children and results in increased healthcare costs to individuals and national healthcare systems.
As the research continues to unfold, a collaborative effort among scientists, healthcare providers, educators and policymakers can unveil new ways of improving the outcomes of childhood obesity and its impact on cancer.
The study represents a call to action, emphasizing the need to tackle the childhood obesity epidemic at its roots to decrease the rates of childhood obesity and solve the problem of long-term implications on cancer survival rates and overall public health.